Onderneming Microbot Medical Inc Nasdaq
Aandelen
US59503A1051
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 02-08-88 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 01-01-22 |
Chief Tech/Sci/R&D Officer | - | 01/12 | |
Simon Sharon
CTO | Chief Tech/Sci/R&D Officer | 64 | 05-04-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 28-11-16 |
Director/Board Member | 66 | 12-12-17 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 01-08-20 |
Harel Gadot
CEO | Chief Executive Officer | 52 | 02-08-88 |
Yossi Bornstein
FOU | Founder | 66 | 02-08-88 |
Martin Madden
BRD | Director/Board Member | 64 | 06-02-17 |
Director/Board Member | 62 | 01-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 14 398 964 | 14 156 936 ( 98,32 %) | 0 | 98,32 % |
Bedrijfsgegevens
Microbot Medical, Inc.
288 Grove Street Suite 388
02184, Braintree
+781 875 3605
http://microbotmedical.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,30% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+5,50% | 24,63 mld. | |
-23,51% | 18,2 mld. | |
+26,87% | 12,01 mld. | |
-3,15% | 11,76 mld. | |
+14,42% | 10,4 mld. | |
-4,11% | 9,94 mld. |